Literature DB >> 32320063

Impact of prebiopsy magnetic resonance imaging on biopsy and radical prostatectomy grade concordance.

Jonathan E Shoag1, Peter Y Cai1, Michael D Gross1, Christopher Gaffney1, Dongze Li2, Jialin Mao2, Molly Nowels2, Douglas S Scherr1, Art Sedrakyan2, Jim C Hu1.   

Abstract

BACKGROUND: Adoption of prostate magnetic resonance imaging (MRI) before biopsy is based on evidence demonstrating superior detection of clinically significant prostate cancer on biopsy. Whether this is due to the detection of otherwise occult higher grade cancers or preferential sampling of higher grade areas within an otherwise low-grade cancer is unknown.
METHODS: To distinguish these two possibilities, this study examined the effect of prebiopsy MRI on the rate of pathologic upgrading and downgrading at prostatectomy in Surveillance, Epidemiology, and End Results-Medicare linked data from 2010 to 2015. Logistic regression was performed to assess the effect of MRI use on the Gleason grade change between biopsy and prostatectomy.
RESULTS: Among biopsy-naive men, those who underwent prebiopsy MRI had higher odds of downgrading at prostatectomy (odds ratio [OR], 1.32; 95% confidence interval [CI], 1.05-1.66). In contrast, the odds of upgrading were significantly lower for men who underwent prebiopsy MRI (OR, 0.78; 95% CI, 0.61-0.99). Limitations included a low overall rate of MRI-utilization prior to biopsy and an inability to distinguish between template, software-assisted and cognitive fusion biopsy.
CONCLUSIONS: Prebiopsy MRI is associated with both oversampling of higher grade areas, which results in downgrading at prostatectomy, and the detection of otherwise occult higher grade lesions, which results in less upgrading at prostatectomy.
© 2020 American Cancer Society.

Entities:  

Keywords:  image-guided biopsy; magnetic resonance imaging; prostatic neoplasms

Year:  2020        PMID: 32320063     DOI: 10.1002/cncr.32821

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Can 68Ga-PSMA-11 PET/CT predict pathological upgrading of prostate cancer from MRI-targeted biopsy to radical prostatectomy?

Authors:  Haoli Yin; Mengxia Chen; Xuefeng Qiu; Li Qiu; Jie Gao; Danyan Li; Yao Fu; Haifeng Huang; Suhan Guo; Qing Zhang; Shuyue Ai; Feng Wang; Hongqian Guo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-04       Impact factor: 9.236

Review 2.  Old men with prostate cancer have higher risk of Gleason score upgrading and pathological upstaging after initial diagnosis: a systematic review and meta-analysis.

Authors:  Xiaochuan Wang; Yu Zhang; Zhengguo Ji; Peiqian Yang; Ye Tian
Journal:  World J Surg Oncol       Date:  2021-01-20       Impact factor: 2.754

3.  Machine Learning-Based Prediction of Pathological Upgrade From Combined Transperineal Systematic and MRI-Targeted Prostate Biopsy to Final Pathology: A Multicenter Retrospective Study.

Authors:  Junlong Zhuang; Yansheng Kan; Yuwen Wang; Alessandro Marquis; Xuefeng Qiu; Marco Oderda; Haifeng Huang; Marco Gatti; Fan Zhang; Paolo Gontero; Linfeng Xu; Giorgio Calleris; Yao Fu; Bing Zhang; Giancarlo Marra; Hongqian Guo
Journal:  Front Oncol       Date:  2022-04-07       Impact factor: 5.738

4.  Combined Systematic and MRI-US Fusion Prostate Biopsy Has the Highest Grading Accuracy When Compared to Final Pathology.

Authors:  Iulia Andras; Emanuel Darius Cata; Andreea Serban; Pierre Kadula; Teodora Telecan; Maximilian Buzoianu; Maria Bungardean; Dan Vasile Stanca; Ioan Coman; Nicolae Crisan
Journal:  Medicina (Kaunas)       Date:  2021-05-22       Impact factor: 2.430

5.  Cancer-specific outcomes for prostate cancer patients who had prebiopsy prostate MRI.

Authors:  Jonathan Li; Dattatraya Patil; Martin G Sanda; Christopher P Filson
Journal:  Urol Oncol       Date:  2021-08-02       Impact factor: 3.498

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.